We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Anaplastic astrocytoma and non-1p/19q co-deleted anaplastic oligoastrocytoma: long-term survival, employment, and performance status of survivors.
- Authors
Pentsova, Elena I.; Reiner, Anne S.; Panageas, Katherine S.; DeAngelis, Lisa M.
- Abstract
Background. Despite optimal treatment for patients with anaplastic gliomas, median survival is 2 to 5 years, but some young adults survive longer. We sought to evaluate the functional and employment status of long-term survivors (5 years or more) diagnosed with anaplastic astrocytoma or non-1p/19q co-deleted anaplastic oligoastrocytoma. Methods. We retrospectively identified patients with a diagnosis of anaplastic glioma at Memorial Sloan Kettering Cancer Center from 1999 to 2005. We reviewed demographics, pathology, 1p/19q status, survival, and treatment. Overall survival was estimated by the Kaplan-Meier method. Results. There were 195 patients; 167 with anaplastic astrocytoma and 28 with anaplastic oligoastrocytoma. All patients were observed either to death or last follow-up. Sixty-four patients (33%) were identified as long-term survivors; 58% of these were men. The median age of the long-term survivors was 39 years and the median Karnofsky Performance Score was 100 at diagnosis. Thirteen patients underwent stereotactic biopsy, 7 had a gross total resection, and 44 a subtotal resection. Fifty-four patients completed radiation therapy as initial treatment; 54 received chemotherapy. Five years following diagnosis, median KPS was 90 and 55% of longterm survivors were employed and remained fully functional. Conclusions. One-third of patients with non-co-deleted anaplastic glioma were long-term survivors, and more than one-half of longterm survivors resumed their prior level of employment and activity. However, a significant proportion could not return to normal function. These findings have serious implications for the social and financial status of these predominantly young adult survivors.
- Subjects
ASTROCYTOMAS; GLIOMAS; TUMORS; MEDICAL care; MEDICAL records
- Publication
Neuro-Oncology Practice, 2016, Vol 3, Issue 2, p71
- ISSN
2054-2577
- Publication type
Article
- DOI
10.1093/nop/npv043